HIGHLIGHTS
- who: Stephanie J. Yaung and colleagues from the and Co, Inc, Kenilworth, NJ, USA. have published the paper: Plasma-Based Measurements of Tumor Heterogeneity Correlate with Clinical Outcomes in Metastatic Colorectal Cancer, in the Journal: Cancers 2022, 14, 2240. of /2022/
- what: The authors explore ctDNA-based heterogeneity and its correlation with treatment outcome in STEAM which assessed efficacy and safety of concurrent and sequential FOLFOXIRI-bevacizumab (BEV) vs. FOLFOX-BEV for first-line treatment of metastatic colorectal The work demonstrates feasibility in targeted sequencing of plasma samples, which offers two advantages.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.